• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自接近中和抗性发展的精英中和抑制剂的祖先序列,作为 HIV 疫苗免疫原的潜在来源。

Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens.

机构信息

Department of Biomolecular Engineering, Baskin School of Engineering, University of California Santa Cruz, Santa Cruz, CA, United States of America.

Monogram Biosciences, South San Francisco, CA, United States of America.

出版信息

PLoS One. 2019 Apr 10;14(4):e0213409. doi: 10.1371/journal.pone.0213409. eCollection 2019.

DOI:10.1371/journal.pone.0213409
PMID:30969970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6457492/
Abstract

A major challenge in HIV vaccine development is the identification of immunogens able to elicit broadly neutralizing antibodies (bNAbs). While remarkable progress has been made in the isolation and characterization of bNAbs, the epitopes they recognize appear to be poorly immunogenic. Thus, none of the candidate vaccines developed to date has induced satisfactory levels of neutralizing antibodies to the HIV envelope protein (Env). One approach to the problem of poor immunogenicity is to build vaccines based on envelope (env) genes retrieved from rare individuals termed elite neutralizers (ENs) who at one time possessed specific sequences that stimulated the formation of bNAbs. Env proteins selected from these individuals could possess uncommon, yet to be defined, structural features that enhance the immunogenicity of epitopes recognized by bNAbs. Here we describe the recovery of envs from an EN that developed unusually broad and potent bNAbs. As longitudinal specimens were not available, we combined plasma and provirus sequences acquired from a single time-point to infer a phylogenetic tree. Combining ancestral reconstruction data with virus neutralization data allowed us to sift through the myriad of virus quasi-species that evolved in this individual to identify envelope sequences from the nodes that appeared to define the transition from neutralization sensitive envs to the neutralization resistant envs that occur in EN plasma. Synthetic genes from these nodes were functional in infectivity assays and sensitive to neutralization by bNAbs, and may provide a novel source of immunogens for HIV vaccine development.

摘要

HIV 疫苗开发的一个主要挑战是鉴定能够引发广泛中和抗体 (bNAb) 的免疫原。虽然在分离和鉴定 bNAb 方面取得了显著进展,但它们识别的表位似乎免疫原性较差。因此,迄今为止开发的候选疫苗都没有诱导出令人满意的 HIV 包膜蛋白 (Env) 中和抗体水平。解决免疫原性差问题的一种方法是基于从称为精英中和者 (EN) 的罕见个体中回收的包膜 (env) 基因构建疫苗,这些个体在某一时刻具有刺激 bNAb 形成的特定序列。从这些个体中选择的 Env 蛋白可能具有不常见但尚未定义的结构特征,从而增强 bNAb 识别表位的免疫原性。在这里,我们描述了从一个产生异常广泛和有效 bNAb 的 EN 中回收 envs 的过程。由于没有纵向标本,我们将从单个时间点获得的血浆和前病毒序列组合在一起,以推断出系统发育树。将祖先重建数据与病毒中和数据相结合,使我们能够从个体中进化出的无数病毒准种中筛选出似乎定义从中和敏感 Env 向 EN 血浆中出现的中和抗性 Env 转变的包膜序列。来自这些节点的合成基因在感染性测定中具有功能,并且对 bNAb 的中和敏感,可能为 HIV 疫苗开发提供新的免疫原来源。

相似文献

1
Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens.来自接近中和抗性发展的精英中和抑制剂的祖先序列,作为 HIV 疫苗免疫原的潜在来源。
PLoS One. 2019 Apr 10;14(4):e0213409. doi: 10.1371/journal.pone.0213409. eCollection 2019.
2
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.从一名感染HIV-1 C亚型的精英中和者体内获得的构象表位特异性广泛中和性血浆抗体通过V1环区的突变介导自体病毒逃逸。
J Virol. 2016 Jan 13;90(7):3446-57. doi: 10.1128/JVI.03090-15.
3
Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development.通过在表位特异性中和广度发展过程中循环的 C 群 HIV-1 CAP257 包膜,快速诱导兔和猕猴产生多功能抗体。
Front Immunol. 2020 Jun 2;11:984. doi: 10.3389/fimmu.2020.00984. eCollection 2020.
4
A Rare Mutation in an Infant-Derived HIV-1 Envelope Glycoprotein Alters Interprotomer Stability and Susceptibility to Broadly Neutralizing Antibodies Targeting the Trimer Apex.婴儿来源的 HIV-1 包膜糖蛋白中的一个罕见突变改变了二聚体间的稳定性,并影响了针对三聚体顶部的广谱中和抗体的敏感性。
J Virol. 2020 Sep 15;94(19). doi: 10.1128/JVI.00814-20.
5
Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses.基于具有早期广泛中和反应的患者的 HIV-1 包膜的病毒样颗粒免疫原可有效诱导包膜特异性抗体应答。
J Virol. 2022 Jan 12;96(1):e0134321. doi: 10.1128/JVI.01343-21. Epub 2021 Oct 20.
6
Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals.长期、低水平的包膜 C2V3 刺激由高度多样化的病毒分离株引起,导致 HIV-1 感染个体中频繁出现广泛且强效的抗体中和作用。
Microbiol Spectr. 2022 Dec 21;10(6):e0163422. doi: 10.1128/spectrum.01634-22. Epub 2022 Nov 29.
7
A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.一种三聚体HIV-1包膜糖蛋白120免疫原在兔和恒河猴中诱导出针对HIV-1的强效且广谱的抗V1V2环抗体。
J Virol. 2018 Feb 12;92(5). doi: 10.1128/JVI.01796-17. Print 2018 Mar 1.
8
An HIV-1 Broadly Neutralizing Antibody from a Clade C-Infected Pediatric Elite Neutralizer Potently Neutralizes the Contemporaneous and Autologous Evolving Viruses.来自 C 型 HIV-1 感染者的广谱中和抗体能有效中和同时代和同源进化的病毒。
J Virol. 2019 Feb 5;93(4). doi: 10.1128/JVI.01495-18. Print 2019 Feb 15.
9
Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing Antibodies.V1 区 gp120 中的罕见半胱氨酸对产生广谱中和抗体的精英抑制剂的影响。
Front Immunol. 2019 May 15;10:1021. doi: 10.3389/fimmu.2019.01021. eCollection 2019.
10
Reduced Potency and Incomplete Neutralization of Broadly Neutralizing Antibodies against Cell-to-Cell Transmission of HIV-1 with Transmitted Founder Envs.针对具有传播奠基者Env的HIV-1细胞间传播的广谱中和抗体的效力降低及中和不完全
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.02425-16. Print 2017 May 1.

引用本文的文献

1
Characterization of Plasma Immunoglobulin G Responses in Elite Neutralizers of Human Cytomegalovirus.精英人类巨细胞病毒中和抗体的血浆免疫球蛋白 G 反应特征。
J Infect Dis. 2022 Nov 1;226(9):1667-1677. doi: 10.1093/infdis/jiac341.
2
Elicitation of potent serum neutralizing antibody responses in rabbits by immunization with an HIV-1 clade C trimeric Env derived from an Indian elite neutralizer.用源自印度精英中和抗体的 HIV-1 型 C 群三聚体 Env 免疫兔子可诱发出强烈的血清中和抗体反应。
PLoS Pathog. 2021 Apr 7;17(4):e1008977. doi: 10.1371/journal.ppat.1008977. eCollection 2021 Apr.
3
Gene editing in CHO cells to prevent proteolysis and enhance glycosylation: Production of HIV envelope proteins as vaccine immunogens.

本文引用的文献

1
Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth.HIV-1 包膜糖蛋白刺突在传播过程中的完整性决定了中和广度。
Cell Rep. 2018 Oct 23;25(4):893-908.e7. doi: 10.1016/j.celrep.2018.09.087.
2
Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies.糖基化修饰 RV144 疫苗试验中使用的 gp120 免疫原可提高与广泛中和抗体的结合能力。
PLoS One. 2018 Apr 24;13(4):e0196370. doi: 10.1371/journal.pone.0196370. eCollection 2018.
3
HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage.
利用 CHO 细胞进行基因编辑以防止蛋白水解和增强糖基化:作为疫苗免疫原的 HIV 包膜蛋白的生产。
PLoS One. 2020 May 29;15(5):e0233866. doi: 10.1371/journal.pone.0233866. eCollection 2020.
HIV包膜糖型异质性和局部多样性决定V2顶端广泛中和抗体谱系的起始和成熟。
Immunity. 2017 Nov 21;47(5):990-1003.e9. doi: 10.1016/j.immuni.2017.11.002.
4
Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies.HIV-1聚糖依赖性广泛中和抗体的阶段性诱导
Sci Transl Med. 2017 Mar 15;9(381). doi: 10.1126/scitranslmed.aai7514.
5
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption.HIV抗体VRC01对治疗中断后病毒反弹的影响。
N Engl J Med. 2016 Nov 24;375(21):2037-2050. doi: 10.1056/NEJMoa1608243. Epub 2016 Nov 9.
6
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability.一种来自精英中和抗体的 HIV-1 抗体表明融合肽是一个脆弱位点。
Nat Microbiol. 2016 Nov 14;2:16199. doi: 10.1038/nmicrobiol.2016.199.
7
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody.从种系到CD4模拟抗体的广泛HIV-1中和剂的成熟途径
Cell. 2016 Apr 7;165(2):449-63. doi: 10.1016/j.cell.2016.02.022. Epub 2016 Mar 3.
8
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort.撒哈拉以南非洲地区大型纵向HIV初次感染队列中的广泛中和抗体反应
PLoS Pathog. 2016 Jan 14;12(1):e1005369. doi: 10.1371/journal.ppat.1005369. eCollection 2016 Jan.
9
Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.预融合HIV-1包膜三聚体与四级结构特异性抗体复合物的免疫原性
J Virol. 2015 Dec 30;90(6):2740-55. doi: 10.1128/JVI.02380-15.
10
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes.非中和表位暴露减少的稳定化HIV-1包膜三聚体的免疫原性
Cell. 2015 Dec 17;163(7):1702-15. doi: 10.1016/j.cell.2015.11.056.